“showed a trend”

Participants with hypoxic burden ≥42%min·h −1 showed a trend towards higher likelihood of significant decline in phonemic fluency (OR 2.26, p=0.033, according to Model 3) ( supplementary tables S10 and S11 ).

Concerning the type of infection, patients showed a trend towards a higher rate of nosocomial infections when sTREM-1 plasma concentrations at V1 were above 532 pg/mL ( p = 0.033), whereas there was no statistical difference when the cut-off of 400 pg/mL was used ( p = 0.154).

In the subgroup study, we demonstrated that compared with RASi, the use of ARNI showed a trend toward reducing the incidence of cardiovascular events, with a statistically significant difference between the two groups (HR 2.811, 95%CI 1.063 − 7.434, p = 0.033), which was consistent with previous research findings.

Of the patients who had prior history of migraine or TTH, we did not observe differences in the frequencies of persistent or non-persistent headache, but patients with pre-existing headache showed a trend to fulfil more ICHD-3 criteria for migraine (p = 0.033; the statistical significance threshold was 0.006 after adjusting for multiple comparisons).

The DMN and VAN also showed a trend of increased IntraNC (DMN: p = .033; VAN: p = .011), but these results failed to reach significance once corrected for multiple comparisons.

E&NS condition showed a trend of higher activation than NE&NS condition ( t (15)=2.35, P =0.033, uncorrected, ES=0.59).

Conversely, in the thalamus, while preclinical scrapie-affected animals showed a trend towards upregulation of SPP1 , a significant upregulation ( p -value = 0.033) was evident in the clinical stage of the disease, compared to healthy controls.

Various blood cell types also showed a trend to association with microbial diversity, including eosinophils which strongly associated with beta diversity when measured by Weighted Unifrac ( p = 0.0334) and Unweighted Unifrac ( p = 0.002).

Previous treatment without bevacizumab showed a trend of effective when combination therapy ( p =0.034).

The treated group showed a trend of reduction in IGF-I levels from days 14 to 28, with a statistically significantly effect ( P = 0.034) at day 21 with a 7% reduction in mean IGF-I levels vs baseline.

Patients operated at high-volume center were more likely to have received neoadjuvant chemotherapy (21.6% versus 8.9%, p = 0.015) and showed a trend for having undergone more frequently RAMPS (51.0% versus 36.0%, p = 0.034).

In addition, patients harboring any of these five fusion genes showed a trend towards worse prognosis ( P =0.034, Figure 4B ).

Concurrent with the weight loss and gene expression changes, the adipocyte perimeter showed a trend towards a more reduced size in the high-nutrient-quality ER diet group when compared to the low-nutrient-quality ER diet group (group comparison, P = 0.034; post hoc analyses: high-nutrient-quality ER diet group compared with control group, P = 0.010; high- compared with low-nutrient-quality ER diet groups, P = 0.098), as assessed in a subset (low-nutrient-quality ER diet group, n = 22; high-nutrient-quality ER diet group, n = 9; control group, n = 10) of the study population.

While transfection with Snail-1 specific siRNA showed a trend toward downregulating vimentin expression in HEC-1A cells following treatment with 60 pmol/mL, this effect did reach statistical significance ( P = 0.034) ( Figure 6b ).

Overall survival showed a trend toward worse prognosis in patients with germline mutations ( P =0.034); however, this difference did not reach statistical significance in multivariate analysis that included age, 2022 ELN risk classification, and allogeneic HCT status (hazard ratio =1.00; 95% confidence interval: 0.53-1.86; P =0.989) ( Online Supplementary Figure S2 ).

The altered group again showed a trend toward reduced DFS, although the median survival could not be calculated due to limited events (p = 0.0345, q = 0.0345).

Rs2241409 showed a trend towards association with grade ≥3 HFS ( p = 0.035), however, this association is not statistically significant at the threshold set in the study ( Rosmarin et al., 2014 ).

The results showed a trend towards a smaller total indirect effect on cognition (coefficient = 0.022 (0.01), p = 0.035) through the vascular risk score, which subsequently influenced WM outcomes (Genu-FA), microbleed occurrence, and, to a lesser extent, tau deposition.

Only endometrioid histology compared with non-endometrioid histology showed a trend to better OS (HR = 0.09, P = 0.035) (Table 2 ).

DRGs treated with human bevacizumab + FUS (nDRGs = 12; voxel: 98.2 ± 43.7; diameter: 0.86 ± 0.14 mm) showed a trend to being smaller ( p = 0.035) than those receiving human bevacizumab alone (nDRGs = 24; voxel: 144.8 ± 72.1; diameter: 1.02 ± 0.17 mm).

Creatinine showed a trend to higher values among obese patients vs. overweight and normal individuals (KW = 6.72; p = 0.035), but not when patients with ascites were excluded (KW = 5.83; p = 0.054); moreover, logistic regression analysis showed that the only variable related to obesity was sclerostin ( p = 0.023).

Each layer showed a trend of increased AFI during the transition from dark adaptation to ambient light, but only the SCP ( P = 0.035) and MCP ( P = 0.011) were significantly higher at 5 minutes of ambient light exposure compared to dark adaptation ( Table 3 ).

While patients from across all three tiers showed a trend to improved Vanderbilt scores (Supplementary Fig. 4 ), only those in Tier 1 showed a statistically significant reduction ( P < 0.035).

In contrast, the variance of max opening velocity showed a trend toward being smaller on the deviated side ( p = 0.035), but this difference did not remain significant after FDR correction (q = 0.070).

Reduced warm glow did not correlate with fear of criticism ( ρ = −0.14, p = 0.290) but showed a trend to be associated with fear of intimacy ( ρ = −0.26, p = 0.035).